✦ LIBER ✦

Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-resistant Prostate Cancer After Docetaxel-based Chemotherapy

✍ Scribed by Mulders, Peter F.A.; Molina, Arturo; Marberger, Michael; Saad, Fred; Higano, Celestia S.; Chi, Kim N.; Li, Jinhui; Kheoh, Thian; Haqq, Christopher M.; Fizazi, Karim

Book ID: 123228077
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 573 KB
Volume: 65
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2013.09.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel-Based Chemotherapy in Elderly

Docetaxel-Based Chemotherapy in Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer

✍ Antoine Italiano; Cécile Ortholan; Stéphane Oudard; Damien Pouessel; Gwenaëlle G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 220 KB

Editorial Comment on: Docetaxel-Based Ch

Editorial Comment on: Docetaxel-Based Chemotherapy in Elderly Patients (Age 75 and Older) with Castration-Resistant Prostate Cancer

✍ Mark A. Rosenthal 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Updated Interim Efficacy Analysis and Lo

Updated Interim Efficacy Analysis and Long-term Safety of Abiraterone Acetate in Metastatic Castration-resistant Prostate Cancer Patients Without Prior Chemotherapy (COU-AA-302)

✍ Rathkopf, Dana E.; Smith, Matthew R.; de Bono, Johann S.; Logothetis, Christophe 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 987 KB

127 Improved survival in elderly (≥75 yr

127 Improved survival in elderly (≥75 yr) metastatic castration-resistant prostate cancer (mCRPC) patients upon treatment with abiraterone acetate (AA) plus prednisone (P) progressing after docetaxel-based chemotherapy: Results from COU-AA-301, a randomized, double-blind, placebo-controlled, phase III study

✍ P.F.A. Mulders; A. Molina; M. Marberger; F. Saad; J.H. Li; T. Kheoh; C.M. Haqq; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 37 KB

784 THE IMPACT OF ABIRATERONE ACETATE TH

784 THE IMPACT OF ABIRATERONE ACETATE THERAPY ON PATIENT-REPORTED PAIN AND FUNCTIONAL STATUS IN CHEMOTHERAPY-NAÏVE PATIENTS WITH PROGRESSIVE, METASTATIC CASTRATION-RESISTANT PROSTATE CANCER - RESULTS FROM AN UPDATED ANALYSIS

✍ Shore, Neal; Basch, Ethan; Ryan, Charles J.; Mulders, Peter; Kheoh, Thian; Fizaz 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 112 KB

705 ABIRATERONE ACETATE PLUS LOW-DOSE PR

705 ABIRATERONE ACETATE PLUS LOW-DOSE PREDNISONE HAS A FAVORABLE SAFETY PROFILE, IMPROVES SURVIVAL AND PRODUCES PSA AND RADIOGRAPHIC RESPONSES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PROGRESSING AFTER DOCETAXEL-BASED CHEMOTHERAPY: RESULTS FROM COU-AA-301, A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE III STUDY

✍ Saad, Fred; de Bono, Johann S.; Haqq, Christopher M.; Logothetis, Christopher J. 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 56 KB